Fulgent Genetics, Inc. (FLGT) › Shareholders' EquityFulgent Genetics, Inc. (FLGT) — Shareholders' EquityAnnual figures by period end, from SEC filings.2013-12-31: $1.97M2014-12-31: $1.68M2015-12-31: $5.15M2016-12-31: $54.48M2017-12-31: $54.18M2018-12-31: $51.15M2019-12-31: $82.78M2020-12-31: $569.39M2021-12-31: $1.16B2022-12-31: $1.27B2023-12-31: $1.14B2024-12-31: $1.13B2025-12-31: $1.11B$1.11B2013-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$1.11B-1.9%2026-02-27Balance as of period end2024-12-31$1.13B-0.3%2026-02-27Balance as of period end2023-12-31$1.14B-10.3%2025-02-28Balance as of period end2022-12-31$1.27B+9.3%2024-02-28Balance as of period end2021-12-31$1.16B+103.5%2023-02-28Balance as of period end2020-12-31$569.39M+587.9%2022-02-28Balance as of period end2019-12-31$82.78M+61.8%2021-03-08Balance as of period end2018-12-31$51.15M-5.6%2021-03-08Balance as of period end2017-12-31$54.18M-0.6%2020-03-13Balance as of period end2016-12-31$54.48M+958.7%2019-03-22Balance as of period end2015-12-31$5.15M+205.6%2018-03-20Balance as of period end2014-12-31$1.68M-14.4%2017-03-17Balance as of period end2013-12-31$1.97M—2017-03-17Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)